Cargando…
Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy
With obesity having doubled in the last decade, hypertension is on the rise. In one-third of hypertensive patients the metabolic syndrome is present. This might be one factor for the increasing number of prescriptions for angiotensin receptor blockers and calcium-channel blockers besides a more favo...
Autores principales: | Ritscher, Sabrina, Hoyer, Milena, Georges, Coralie, Wunder, Cora, Wallemacq, Pierre, Persu, Alexandre, Obermüller, Nicholas, Toennes, Stefan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416922/ https://www.ncbi.nlm.nih.gov/pubmed/32776967 http://dx.doi.org/10.1371/journal.pone.0237383 |
Ejemplares similares
-
Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers – drug classes with low adherence in antihypertensive therapy
por: Ritscher, Sabrina, et al.
Publicado: (2019) -
Drug adherence and psychological factors in patients with apparently treatment‐resistant hypertension: Yes but which ones?
por: Georges, Coralie M. G., et al.
Publicado: (2022) -
Measuring Adherence to Antihypertensive Drug Therapy
por: D'Souza, Anna
Publicado: (2004) -
The Impact of Non-Adherence to Antihypertensive Drug Therapy
por: Gardezi, Syed Karam Mustafa, et al.
Publicado: (2023) -
Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China
por: Ma, Xiaochen, et al.
Publicado: (2019)